Therapeutic Effects of Shenfu Injection in Shock

Zhang, Mingqing; Li, Chunsheng

doi:10.1007/s11655-023-3631-2

Cited by 2 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SFI ( Figure 1 ) is widely used in China to treat numerous ailments, including shock ( Zhang X. et al, 2020 ; Wang et al, 2022 ; Zhang and Li, 2023 ), pulmonary fibrosis ( Liu et al, 2021 ), sepsis ( Luo et al, 2021 ; Li X. et al, 2022 ; Xu et al, 2022 ), pneumonia ( Niu et al, 2021 ; Shi et al, 2022 ), cancer ( Gao and Zhang, 2023 ; Wen et al, 2023 ), cercerebral infarction ( Zhou et al, 2020 ), CVDs, and has shown promising results. With development of pharmacological research, SFI has been identified as an effective drug for the treatment of CVDs.This paper reviews the latest reports in the past 20 years (2003–2022) from PubMed, Web of Science, and National Knowledge Infrastructure (CNKI) using the keywords “Shenfu injection” and “cardiovascular diseases”.…”

Section: Introductionmentioning

confidence: 99%

Shenfu injection: a review of pharmacological effects on cardiovascular diseases

Xu,

Xie,

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

Shenfu injection (SFI), composed of ginseng and aconite, is a Chinese patent developed from the classic traditional prescription Shenfu Decoction created more than 700 years ago. SFI has been widely used in China for over 30 years for treating cardiovascular diseases. The main components in it include ginsenosides and aconitum alkaloids. In recent years, the role of SFI in the treatment of cardiovascular diseases has attracted much attention. The pharmacological effects and therapeutic applications of SFI in cardiovascular diseases are summarized here, highlighting pharmacological features and potential mechanisms developments, confirming that SFI can play a role in multiple ways and is a promising drug for treating cardiovascular diseases.

show abstract